140 related articles for article (PubMed ID: 38212958)
1. Understanding the pathogenic mechanisms and therapeutic effects in neurocysticercosis.
Castillo G; Fustamante L; Delgado-Kamiche AD; Camen-Orozco RP; Clark T; Bernal E; Morales-Alvarez J; Ferrufino M; Mamani-Palomino J; Bustos JA; Garcia HH; Gavidia CM; Gilman RH; Verastegui M;
Brain Pathol; 2024 Jan; ():e13237. PubMed ID: 38212958
[TBL] [Abstract][Full Text] [Related]
2. Oxfendazole induces protein catabolism and gluconeogenesis in experimental neurocysticercosis.
Correia LTB; de Lima NF; Gomes TC; De Sousa Guerra CH; Costa TL; Vinaud MC
Acta Trop; 2022 Oct; 234():106571. PubMed ID: 35752205
[TBL] [Abstract][Full Text] [Related]
3. Anthelmintics for people with neurocysticercosis.
Monk EJM; Abba K; Ranganathan LN
Cochrane Database Syst Rev; 2021 Jun; 6(6):CD000215. PubMed ID: 34060667
[TBL] [Abstract][Full Text] [Related]
4. Axonal swellings and spheroids: a new insight into the pathology of neurocysticercosis.
Mejia Maza A; Carmen-Orozco RP; Carter ES; Dávila-Villacorta DG; Castillo G; Morales JD; Mamani J; Gavídia CM; Alroy J; Sterling CR; Gonzalez AE; García HH; Woltjer RL; Verástegui MR; Gilman RH;
Brain Pathol; 2019 May; 29(3):425-436. PubMed ID: 30368965
[TBL] [Abstract][Full Text] [Related]
5. Radiological evolution of porcine neurocysticercosis after combined antiparasitic treatment with praziquantel and albendazole.
Cangalaya C; Bustos JA; Calcina J; Vargas-Calla A; Mamani J; Suarez D; Arroyo G; Gonzalez AE; Chacaltana J; Guerra-Giraldez C; Mahanty S; Nash TE; García HH;
PLoS Negl Trop Dis; 2017 Jun; 11(6):e0005624. PubMed ID: 28575043
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis.
Garcia HH; Lescano AG; Lanchote VL; Pretell EJ; Gonzales I; Bustos JA; Takayanagui OM; Bonato PS; Horton J; Saavedra H; Gonzalez AE; Gilman RH;
Br J Clin Pharmacol; 2011 Jul; 72(1):77-84. PubMed ID: 21332573
[TBL] [Abstract][Full Text] [Related]
7. Sensitive in vitro system to assess morphological and biochemical effects of praziquantel and albendazole on Taenia solium cysts.
Mahanty S; Paredes A; Marzal M; Gonzalez E; Rodriguez S; Dorny P; Guerra-Giraldez C; Garcia HH; Nash T
Antimicrob Agents Chemother; 2011 Jan; 55(1):211-7. PubMed ID: 21041508
[TBL] [Abstract][Full Text] [Related]
8. Disruption of the blood-brain barrier in pigs naturally infected with Taenia solium, untreated and after anthelmintic treatment.
Guerra-Giraldez C; Marzal M; Cangalaya C; Balboa D; Orrego MÁ; Paredes A; Gonzales-Gustavson E; Arroyo G; García HH; González AE; Mahanty S; Nash TE;
Exp Parasitol; 2013 Aug; 134(4):443-6. PubMed ID: 23684909
[TBL] [Abstract][Full Text] [Related]
9. Cysticidal Efficacy of Combined Treatment With Praziquantel and Albendazole for Parenchymal Brain Cysticercosis.
Garcia HH; Lescano AG; Gonzales I; Bustos JA; Pretell EJ; Horton J; Saavedra H; Gonzalez AE; Gilman RH;
Clin Infect Dis; 2016 Jun; 62(11):1375-9. PubMed ID: 26984901
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of oxfendazole, praziquantel and albendazole against cystic echinococcosis: a randomized clinical trial in naturally infected sheep.
Gavidia CM; Gonzalez AE; Barron EA; Ninaquispe B; Llamosas M; Verastegui MR; Robinson C; Gilman RH
PLoS Negl Trop Dis; 2010 Feb; 4(2):e616. PubMed ID: 20186332
[TBL] [Abstract][Full Text] [Related]
11. Monitoring treatment of Taenia solium- neurocysticercosis by detection of circulating antigens: a case report.
Rodríguez-Hidalgo R; Carpio A; Van den Enden E; Benítez-Ortiz W
BMC Neurol; 2019 Apr; 19(1):52. PubMed ID: 30943908
[TBL] [Abstract][Full Text] [Related]
12. TNF-α blockade suppresses pericystic inflammation following anthelmintic treatment in porcine neurocysticercosis.
Mahanty S; Orrego MA; Cangalaya C; Adrianzen MP; Arroyo G; Calcina J; Gonzalez AE; García HH; Guerra-Giraldez C; Nash TE;
PLoS Negl Trop Dis; 2017 Nov; 11(11):e0006059. PubMed ID: 29190292
[TBL] [Abstract][Full Text] [Related]
13. Novel rat model for neurocysticercosis using Taenia solium.
Verastegui MR; Mejia A; Clark T; Gavidia CM; Mamani J; Ccopa F; Angulo N; Chile N; Carmen R; Medina R; García HH; Rodriguez S; Ortega Y; Gilman RH
Am J Pathol; 2015 Aug; 185(8):2259-68. PubMed ID: 26216286
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of antiparasitic therapy for neurocysticercosis in rural Tanzania: a prospective cohort study.
Stelzle D; Makasi C; Schmidt V; Trevisan C; Van Damme I; Ruether C; Dorny P; Magnussen P; Zulu G; Mwape KE; Bottieau E; Prazeres da Costa C; Prodjinotho UF; Carabin H; Jackson E; Fleury A; Gabriël S; Ngowi BJ; Winkler AS
Infection; 2023 Aug; 51(4):1127-1139. PubMed ID: 36961623
[TBL] [Abstract][Full Text] [Related]
15. Post-treatment vascular leakage and inflammatory responses around brain cysts in porcine neurocysticercosis.
Mahanty S; Orrego MA; Mayta H; Marzal M; Cangalaya C; Paredes A; Gonzales-Gustavson E; Arroyo G; Gonzalez AE; Guerra-Giraldez C; García HH; Nash TE;
PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003577. PubMed ID: 25774662
[TBL] [Abstract][Full Text] [Related]
16. Albendazole - Ivermectin combination decreases inflammation in experimental neurocysticercosis.
da Silva Santana RC; Prudente TP; de Sousa Guerra CH; de Lima NF; de Souza Lino Junior R; Vinaud MC
Exp Parasitol; 2023 Aug; 251():108568. PubMed ID: 37327965
[TBL] [Abstract][Full Text] [Related]
17. Routine drug and food interactions during antihelminthic treatment of neurocysticercosis: a reason for the variable efficacy of albendazole and praziquantel?
Romo ML; Carpio A; Kelvin EA
J Clin Pharmacol; 2014 Apr; 54(4):361-7. PubMed ID: 24443292
[TBL] [Abstract][Full Text] [Related]
18. Antiparasitic treatment of neurocysticercosis - The effect of cyst destruction in seizure evolution.
Garcia HH; Del Brutto OH;
Epilepsy Behav; 2017 Nov; 76():158-162. PubMed ID: 28606690
[TBL] [Abstract][Full Text] [Related]
19. Perilesional Inflammation in Neurocysticercosis - Relationship Between Contrast-Enhanced Magnetic Resonance Imaging, Evans Blue Staining and Histopathology in the Pig Model.
Cangalaya C; Bustos JA; Calcina J; Vargas-Calla A; Suarez D; Gonzalez AE; Chacaltana J; Guerra-Giraldez C; Mahanty S; Nash TE; García HH;
PLoS Negl Trop Dis; 2016 Jul; 10(7):e0004869. PubMed ID: 27459388
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic variability of anthelmintics: implications for the treatment of neurocysticercosis.
Jung-Cook H
Expert Rev Clin Pharmacol; 2012 Jan; 5(1):21-30. PubMed ID: 22142156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
